AU2003266302A1 - Method for the diagnosis of alzheimer disease - Google Patents
Method for the diagnosis of alzheimer diseaseInfo
- Publication number
- AU2003266302A1 AU2003266302A1 AU2003266302A AU2003266302A AU2003266302A1 AU 2003266302 A1 AU2003266302 A1 AU 2003266302A1 AU 2003266302 A AU2003266302 A AU 2003266302A AU 2003266302 A AU2003266302 A AU 2003266302A AU 2003266302 A1 AU2003266302 A1 AU 2003266302A1
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- alzheimer disease
- alzheimer
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40530002P | 2002-08-23 | 2002-08-23 | |
| US60/405,300 | 2002-08-23 | ||
| PCT/EP2003/009300 WO2004019045A2 (en) | 2002-08-23 | 2003-08-21 | Method for the diagnosis of alzheimer disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003266302A1 true AU2003266302A1 (en) | 2004-03-11 |
Family
ID=31946851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003266302A Abandoned AU2003266302A1 (en) | 2002-08-23 | 2003-08-21 | Method for the diagnosis of alzheimer disease |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003266302A1 (en) |
| WO (1) | WO2004019045A2 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10303974A1 (en) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid β (1-42) oligomers, process for their preparation and their use |
| KR101434935B1 (en) | 2005-11-30 | 2014-10-01 | 애브비 인코포레이티드 | Monoclonal Antibodies to Amyloid Beta Proteins and Their Uses |
| RU2442793C2 (en) | 2005-11-30 | 2012-02-20 | Эбботт Лэборетриз | ANTISUBSTANCES AGAINST GLOBULOMER Aβ, THEIR ANTIGEN-BINDING PARTS, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, WAYS OF PRODUCTION OF MENTIONED ANTISUBSTANCES, COMPOSITIONS CONTAINING MENTIONED ANTISUBSTANCES, APPLICATION OF MENTIONED ANTISUBSTANCES AND WAYS OF APPLICATION OF MENTIONED ANTISUBSTANCES |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| WO2008104386A2 (en) | 2007-02-27 | 2008-09-04 | Abbott Gmbh & Co. Kg | Method for the treatment of amyloidoses |
| WO2010084150A1 (en) * | 2009-01-23 | 2010-07-29 | Proteosys Ag | Diagnostic method for detecting neurodegenerative diseases |
| MX360403B (en) | 2010-04-15 | 2018-10-31 | Abbvie Inc | Amyloid-beta binding proteins. |
| EP2603524A1 (en) | 2010-08-14 | 2013-06-19 | AbbVie Inc. | Amyloid-beta binding proteins |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5985581A (en) * | 1996-07-25 | 1999-11-16 | The Mclean Hospital Corporation | Use of presenilin-1 for diagnosis of alzheimers disease |
| US6602851B1 (en) * | 1999-10-08 | 2003-08-05 | Uab Research Foundation | SMDF and GGF neuregulin splice variant isoforms and uses thereof |
| US7538197B2 (en) * | 2000-02-11 | 2009-05-26 | Proteosys Ag | Use of neuregulin-β as an indicator and/or target |
| US7824923B2 (en) * | 2001-08-06 | 2010-11-02 | Proteosys Ag | Neuregulin-β isoforms associated with neuronal processes |
-
2003
- 2003-08-21 AU AU2003266302A patent/AU2003266302A1/en not_active Abandoned
- 2003-08-21 WO PCT/EP2003/009300 patent/WO2004019045A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004019045A3 (en) | 2004-04-01 |
| WO2004019045A2 (en) | 2004-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003219690A1 (en) | Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease | |
| AU2003301347A1 (en) | Methods for monitoring treatment of disease | |
| EP1940373B8 (en) | 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease | |
| AU2003274346A1 (en) | Method for prediction of cardiac disease | |
| IL188165A0 (en) | Method for the diagnosis of alzheimer's disease | |
| AU2002950878A0 (en) | Method for diagnosing disorders | |
| AU2003217275A1 (en) | Azabicyclic compounds for the treatment of disease | |
| AU2003219359A1 (en) | Imaging method | |
| AU2003266302A1 (en) | Method for the diagnosis of alzheimer disease | |
| AU2003260983A1 (en) | Processes for the preparation of s-(-)-amlodipine | |
| AU2003223780A1 (en) | Treatment for pompe disease | |
| AU2003283648A1 (en) | Compounds as radioligands for the diagnosis of disease | |
| AU2003201630A1 (en) | A method for the diagnosis of lymphoproliferative diseases | |
| AU2002367890A1 (en) | Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate | |
| AU2003277202A1 (en) | Methods for diagnosing bone turnover disease | |
| AU2003299101A1 (en) | Compounds for the treatment of alzheimer's disease | |
| AU2003283732A1 (en) | Method of tomographic imaging | |
| AU2003251962A1 (en) | Screening for alzheimer's disease | |
| AU2003294206A1 (en) | Methods for diagnosing htlv-i-mediated diseases | |
| AU2003258622A1 (en) | Method for the production of $g(b)-carotinoids | |
| AU2004225794A8 (en) | Process for the electrolysis of aluminiumsulfide | |
| EP1693671A4 (en) | Method of diagnosing alzheimer's disease | |
| AU2003269482A1 (en) | Process for the manufacture of 2,1,3-benzoxadiazole-4-carboxaldehyde | |
| PT1639139E (en) | Methods for the diagnosis and prognosis of alzheimer`s disease | |
| AU2003267541A1 (en) | Method for the production of substituted trifluoroethylenes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |